Search research articles
Contact Us
Filters
Showing results (831-840 of 920) with videos related to
Page
of 92
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2021
Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer
Ying Jin, Yamei Chen, Huarong Tang, et al.
Translational Lung Cancer Research
|
September 29, 2021
The Chinese Thoracic Oncology Group (CTONG) therapeutic option scoring system: a multiple-parameter framework to assess the value of lung cancer treatment options
Jiu-Wei Cui, Qing Zhou, Shun Lu, et al.
The Journal of Antimicrobial Chemotherapy
|
July 16, 2024
Establishment of epidemiological cut-off values for eravacycline, against Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Acinetobacter baumannii and Staphylococcus aureus
Ran Jing, Qiao-Lian Yi, Chao Zhuo, et al.
Nature Medicine
|
August 19, 2025
First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial
Shaodong Hong, Qiming Wang, Ying Cheng, et al.
The New England Journal of Medicine
|
December 21, 2007
Telbivudine versus lamivudine in patients with chronic hepatitis B
Ching-Lung Lai, Edward Gane, Yun-Fan Liaw, et al.
The New England Journal of Medicine
|
November 8, 2023
Osimertinib with or without Chemotherapy in <i>EGFR</i>-Mutated Advanced NSCLC
David Planchard, Pasi A Jänne, Ying Cheng, et al.
JTO Clinical and Research Reports
|
October 11, 2022
Long-Term Efficacy, Safety, and Subgroup Analysis of Savolitinib in Chinese Patients With NSCLCs Harboring <i>MET</i> Exon 14 Skipping Alterations
Shun Lu, Jian Fang, Xingya Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 15, 2021
Safety but Limited Efficacy of Ensartinib in ROS1-Positive NSCLC: A Single-Arm, Multicenter Phase 2 Study
Xinghao Ai, Qiming Wang, Ying Cheng, et al.
Cancer Letters
|
June 6, 2026
Multi-Omic Profiling Identifies TREM2<sup>+</sup> Lipid-laden Macrophages as Inflammatory Drivers and Therapeutic Targets of Colorectal Cancer Liver Metastasis
Peng-Xiang Wang, Yu-Chen Zhong, Wen-Jing Zheng, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 9, 2026
k5-mediated microglial ferroptosis drives ischemic white matter damage via the Nfatc4-Clptm1l axis
Yun-Hui Chu, Lu-Yang Zhang, Jia-Yi He, et al.
Page
of 92
Search research articles
Search
Showing results (831-840 of 920) with videos related to
Sort By:
Page
of 92
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2021
Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer
Ying Jin, Yamei Chen, Huarong Tang, et al.
Translational Lung Cancer Research
|
September 29, 2021
The Chinese Thoracic Oncology Group (CTONG) therapeutic option scoring system: a multiple-parameter framework to assess the value of lung cancer treatment options
Jiu-Wei Cui, Qing Zhou, Shun Lu, et al.
The Journal of Antimicrobial Chemotherapy
|
July 16, 2024
Establishment of epidemiological cut-off values for eravacycline, against Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Acinetobacter baumannii and Staphylococcus aureus
Ran Jing, Qiao-Lian Yi, Chao Zhuo, et al.
Nature Medicine
|
August 19, 2025
First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial
Shaodong Hong, Qiming Wang, Ying Cheng, et al.
The New England Journal of Medicine
|
December 21, 2007
Telbivudine versus lamivudine in patients with chronic hepatitis B
Ching-Lung Lai, Edward Gane, Yun-Fan Liaw, et al.
The New England Journal of Medicine
|
November 8, 2023
Osimertinib with or without Chemotherapy in <i>EGFR</i>-Mutated Advanced NSCLC
David Planchard, Pasi A Jänne, Ying Cheng, et al.
JTO Clinical and Research Reports
|
October 11, 2022
Long-Term Efficacy, Safety, and Subgroup Analysis of Savolitinib in Chinese Patients With NSCLCs Harboring <i>MET</i> Exon 14 Skipping Alterations
Shun Lu, Jian Fang, Xingya Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 15, 2021
Safety but Limited Efficacy of Ensartinib in ROS1-Positive NSCLC: A Single-Arm, Multicenter Phase 2 Study
Xinghao Ai, Qiming Wang, Ying Cheng, et al.
Cancer Letters
|
June 6, 2026
Multi-Omic Profiling Identifies TREM2<sup>+</sup> Lipid-laden Macrophages as Inflammatory Drivers and Therapeutic Targets of Colorectal Cancer Liver Metastasis
Peng-Xiang Wang, Yu-Chen Zhong, Wen-Jing Zheng, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 9, 2026
k5-mediated microglial ferroptosis drives ischemic white matter damage via the Nfatc4-Clptm1l axis
Yun-Hui Chu, Lu-Yang Zhang, Jia-Yi He, et al.
Page
of 92